Breast cancer classification relies on the evaluation of hormone receptor status, including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression [3]. This evidence concerns the gene ESR1 and breast carcinoma.